Clinical Trial Update: Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy and safety of oral alitretinoin (Toctino) in patients with cutaneous lupus erythematosus. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus

Drugs mentioned

• Toctino (alitretinoin)

Snippet

Sponsor: University Hospital Muenster | Conditions: Lupus Erythematosus, Cutaneous | Phase 2 | Status: TERMINATED